Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Geniom Technology Applied to Targeted Next-Generation Sequencing

Published: Tuesday, July 24, 2007
Last Updated: Wednesday, July 25, 2007
Bookmark and Share
By enabling selective targeting, the Geniom® Biochip will allow researchers to sequence individual and well defined parts of genomes

febit biotech gmbh has achieved a first milestone in a product development project whose outcome should remove one of the major bottlenecks of next-generation sequencing platforms.

By enabling selective targeting, the Geniom® Biochip will allow researchers to sequence individual and well defined parts of genomes. Many scientists believe that such targeted sequencing – especially in the medical and diagnostic context - will be a significant application in genomics.

The project is carried out in conjunction with the Illumina/Solexa platform as representative of Next-Generation DNA sequencing instruments. The application might as well serve users of other systems such as the 454 sequencer instrument and the ABI/Agencourt system. febit’s work is a continuation of earlier research addressing uses of its Geniom microfluidic microarray technology.

febit CSO Peer Stahler: “We strongly believe that the products and services resulting from this project will open important and innovative analytical windows on the Genome. The resulting applications could change the way DNA sequence information is used in research and medical diagnostics. We are working with several partners in this field and expect first products to be available in 2008.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Febit Establishes US Company
Febit launches the GENIOM biochip system in the US.
Tuesday, August 15, 2006
Febit Achieves Sales Goals
Febit successfully markets the GENIOM bioanalysis device.
Thursday, March 16, 2006
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Gene-Editing Improves Vision in Blind Rats
Scientists developed a targeted gene-replacement technique that can modify genes in both dividing and non-dividing cells in living animals.
Gene Editing Yields Tomatoes That Ripen Weeks Earlier
Research team develop method to make tomato plants flower and ripen fruit two weeks faster than current growth rates.
Exploring the Genome of the River Blindness Parasite
Researchers have decoded the genome of the parasite that causes the skin and eye infection known as river blindness.
Unexpected Role for Epigenetic Enzymes in Cancer
Researchers use epigenetics to identify the role of an enzyme family as regulators of genetic message interpretation in yeast.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!